Global Plasma-derived Medicinal Products Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Plasma-derived Medicinal Products Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Plasma-derived Medicinal Products by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Plasma-derived Medicinal Products by Country/Region, 2017, 2022 & 2028

2.2 Plasma-derived Medicinal Products Segment by Type

2.2.1 Immunoglobulins

2.2.2 Coagulation Factor Concentrates

2.2.3 Other

2.3 Plasma-derived Medicinal Products Sales by Type

2.3.1 Global Plasma-derived Medicinal Products Sales Market Share by Type (2017-2022)

2.3.2 Global Plasma-derived Medicinal Products Revenue and Market Share by Type (2017-2022)

2.3.3 Global Plasma-derived Medicinal Products Sale Price by Type (2017-2022)

2.4 Plasma-derived Medicinal Products Segment by Application

2.4.1 Emergency Care

2.4.2 Epidemic Diseasae

2.4.3 Immune System Disorder

2.4.4 Antibody Deficiency

2.4.5 Coagulation Disorder

2.4.6 Others

2.5 Plasma-derived Medicinal Products Sales by Application

2.5.1 Global Plasma-derived Medicinal Products Sale Market Share by Application (2017-2022)

2.5.2 Global Plasma-derived Medicinal Products Revenue and Market Share by Application (2017-2022)

2.5.3 Global Plasma-derived Medicinal Products Sale Price by Application (2017-2022)

3 Global Plasma-derived Medicinal Products by Company

3.1 Global Plasma-derived Medicinal Products Breakdown Data by Company

3.1.1 Global Plasma-derived Medicinal Products Annual Sales by Company (2020-2022)

3.1.2 Global Plasma-derived Medicinal Products Sales Market Share by Company (2020-2022)

3.2 Global Plasma-derived Medicinal Products Annual Revenue by Company (2020-2022)

3.2.1 Global Plasma-derived Medicinal Products Revenue by Company (2020-2022)

3.2.2 Global Plasma-derived Medicinal Products Revenue Market Share by Company (2020-2022)

3.3 Global Plasma-derived Medicinal Products Sale Price by Company

3.4 Key Manufacturers Plasma-derived Medicinal Products Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Plasma-derived Medicinal Products Product Location Distribution

3.4.2 Players Plasma-derived Medicinal Products Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Plasma-derived Medicinal Products by Geographic Region

4.1 World Historic Plasma-derived Medicinal Products Market Size by Geographic Region (2017-2022)

4.1.1 Global Plasma-derived Medicinal Products Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Plasma-derived Medicinal Products Annual Revenue by Geographic Region

4.2 World Historic Plasma-derived Medicinal Products Market Size by Country/Region (2017-2022)

4.2.1 Global Plasma-derived Medicinal Products Annual Sales by Country/Region (2017-2022)

4.2.2 Global Plasma-derived Medicinal Products Annual Revenue by Country/Region

4.3 Americas Plasma-derived Medicinal Products Sales Growth

4.4 APAC Plasma-derived Medicinal Products Sales Growth

4.5 Europe Plasma-derived Medicinal Products Sales Growth

4.6 Middle East & Africa Plasma-derived Medicinal Products Sales Growth

5 Americas

5.1 Americas Plasma-derived Medicinal Products Sales by Country

5.1.1 Americas Plasma-derived Medicinal Products Sales by Country (2017-2022)

5.1.2 Americas Plasma-derived Medicinal Products Revenue by Country (2017-2022)

5.2 Americas Plasma-derived Medicinal Products Sales by Type

5.3 Americas Plasma-derived Medicinal Products Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Plasma-derived Medicinal Products Sales by Region

6.1.1 APAC Plasma-derived Medicinal Products Sales by Region (2017-2022)

6.1.2 APAC Plasma-derived Medicinal Products Revenue by Region (2017-2022)

6.2 APAC Plasma-derived Medicinal Products Sales by Type

6.3 APAC Plasma-derived Medicinal Products Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Plasma-derived Medicinal Products by Country

7.1.1 Europe Plasma-derived Medicinal Products Sales by Country (2017-2022)

7.1.2 Europe Plasma-derived Medicinal Products Revenue by Country (2017-2022)

7.2 Europe Plasma-derived Medicinal Products Sales by Type

7.3 Europe Plasma-derived Medicinal Products Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Plasma-derived Medicinal Products by Country

8.1.1 Middle East & Africa Plasma-derived Medicinal Products Sales by Country (2017-2022)

8.1.2 Middle East & Africa Plasma-derived Medicinal Products Revenue by Country (2017-2022)

8.2 Middle East & Africa Plasma-derived Medicinal Products Sales by Type

8.3 Middle East & Africa Plasma-derived Medicinal Products Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Plasma-derived Medicinal Products

10.3 Manufacturing Process Analysis of Plasma-derived Medicinal Products

10.4 Industry Chain Structure of Plasma-derived Medicinal Products

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Plasma-derived Medicinal Products Distributors

11.3 Plasma-derived Medicinal Products Customer

12 World Forecast Review for Plasma-derived Medicinal Products by Geographic Region

12.1 Global Plasma-derived Medicinal Products Market Size Forecast by Region

12.1.1 Global Plasma-derived Medicinal Products Forecast by Region (2023-2028)

12.1.2 Global Plasma-derived Medicinal Products Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Plasma-derived Medicinal Products Forecast by Type

12.7 Global Plasma-derived Medicinal Products Forecast by Application

13 Key Players Analysis

13.1 Novartis(CSL Limited)

13.1.1 Novartis(CSL Limited) Company Information

13.1.2 Novartis(CSL Limited) Plasma-derived Medicinal Products Product Offered

13.1.3 Novartis(CSL Limited) Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novartis(CSL Limited) Main Business Overview

13.1.5 Novartis(CSL Limited) Latest Developments

13.2 Biotest AG (Creat Group Corporation)

13.2.1 Biotest AG (Creat Group Corporation) Company Information

13.2.2 Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Product Offered

13.2.3 Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Biotest AG (Creat Group Corporation) Main Business Overview

13.2.5 Biotest AG (Creat Group Corporation) Latest Developments

13.3 Grifols SA

13.3.1 Grifols SA Company Information

13.3.2 Grifols SA Plasma-derived Medicinal Products Product Offered

13.3.3 Grifols SA Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Grifols SA Main Business Overview

13.3.5 Grifols SA Latest Developments

13.4 Sigma-Aldrich

13.4.1 Sigma-Aldrich Company Information

13.4.2 Sigma-Aldrich Plasma-derived Medicinal Products Product Offered

13.4.3 Sigma-Aldrich Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Sigma-Aldrich Main Business Overview

13.4.5 Sigma-Aldrich Latest Developments

13.5 Thermo Fisher Scientific

13.5.1 Thermo Fisher Scientific Company Information

13.5.2 Thermo Fisher Scientific Plasma-derived Medicinal Products Product Offered

13.5.3 Thermo Fisher Scientific Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Thermo Fisher Scientific Main Business Overview

13.5.5 Thermo Fisher Scientific Latest Developments

13.6 Octapharma AG

13.6.1 Octapharma AG Company Information

13.6.2 Octapharma AG Plasma-derived Medicinal Products Product Offered

13.6.3 Octapharma AG Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Octapharma AG Main Business Overview

13.6.5 Octapharma AG Latest Developments

13.7 Takeda

13.7.1 Takeda Company Information

13.7.2 Takeda Plasma-derived Medicinal Products Product Offered

13.7.3 Takeda Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Takeda Main Business Overview

13.7.5 Takeda Latest Developments

13.8 Kedrion

13.8.1 Kedrion Company Information

13.8.2 Kedrion Plasma-derived Medicinal Products Product Offered

13.8.3 Kedrion Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Kedrion Main Business Overview

13.8.5 Kedrion Latest Developments

13.9 China Biologic Products

13.9.1 China Biologic Products Company Information

13.9.2 China Biologic Products Plasma-derived Medicinal Products Product Offered

13.9.3 China Biologic Products Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 China Biologic Products Main Business Overview

13.9.5 China Biologic Products Latest Developments

13.10 LFB Group

13.10.1 LFB Group Company Information

13.10.2 LFB Group Plasma-derived Medicinal Products Product Offered

13.10.3 LFB Group Plasma-derived Medicinal Products Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 LFB Group Main Business Overview

13.10.5 LFB Group Latest Developments

14 Research Findings and Conclusion

Table 1. Plasma-derived Medicinal Products Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Plasma-derived Medicinal Products Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Immunoglobulins

Table 4. Major Players of Coagulation Factor Concentrates

Table 5. Major Players of Other

Table 6. Global Plasma-derived Medicinal Products Sales by Type (2017-2022) & (K Units)

Table 7. Global Plasma-derived Medicinal Products Sales Market Share by Type (2017-2022)

Table 8. Global Plasma-derived Medicinal Products Revenue by Type (2017-2022) & ($ million)

Table 9. Global Plasma-derived Medicinal Products Revenue Market Share by Type (2017-2022)

Table 10. Global Plasma-derived Medicinal Products Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Plasma-derived Medicinal Products Sales by Application (2017-2022) & (K Units)

Table 12. Global Plasma-derived Medicinal Products Sales Market Share by Application (2017-2022)

Table 13. Global Plasma-derived Medicinal Products Revenue by Application (2017-2022)

Table 14. Global Plasma-derived Medicinal Products Revenue Market Share by Application (2017-2022)

Table 15. Global Plasma-derived Medicinal Products Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Plasma-derived Medicinal Products Sales by Company (2020-2022) & (K Units)

Table 17. Global Plasma-derived Medicinal Products Sales Market Share by Company (2020-2022)

Table 18. Global Plasma-derived Medicinal Products Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Plasma-derived Medicinal Products Revenue Market Share by Company (2020-2022)

Table 20. Global Plasma-derived Medicinal Products Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Plasma-derived Medicinal Products Producing Area Distribution and Sales Area

Table 22. Players Plasma-derived Medicinal Products Products Offered

Table 23. Plasma-derived Medicinal Products Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Plasma-derived Medicinal Products Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Plasma-derived Medicinal Products Sales Market Share Geographic Region (2017-2022)

Table 28. Global Plasma-derived Medicinal Products Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Plasma-derived Medicinal Products Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Plasma-derived Medicinal Products Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Plasma-derived Medicinal Products Sales Market Share by Country/Region (2017-2022)

Table 32. Global Plasma-derived Medicinal Products Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Plasma-derived Medicinal Products Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Plasma-derived Medicinal Products Sales by Country (2017-2022) & (K Units)

Table 35. Americas Plasma-derived Medicinal Products Sales Market Share by Country (2017-2022)

Table 36. Americas Plasma-derived Medicinal Products Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Plasma-derived Medicinal Products Revenue Market Share by Country (2017-2022)

Table 38. Americas Plasma-derived Medicinal Products Sales by Type (2017-2022) & (K Units)

Table 39. Americas Plasma-derived Medicinal Products Sales Market Share by Type (2017-2022)

Table 40. Americas Plasma-derived Medicinal Products Sales by Application (2017-2022) & (K Units)

Table 41. Americas Plasma-derived Medicinal Products Sales Market Share by Application (2017-2022)

Table 42. APAC Plasma-derived Medicinal Products Sales by Region (2017-2022) & (K Units)

Table 43. APAC Plasma-derived Medicinal Products Sales Market Share by Region (2017-2022)

Table 44. APAC Plasma-derived Medicinal Products Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Plasma-derived Medicinal Products Revenue Market Share by Region (2017-2022)

Table 46. APAC Plasma-derived Medicinal Products Sales by Type (2017-2022) & (K Units)

Table 47. APAC Plasma-derived Medicinal Products Sales Market Share by Type (2017-2022)

Table 48. APAC Plasma-derived Medicinal Products Sales by Application (2017-2022) & (K Units)

Table 49. APAC Plasma-derived Medicinal Products Sales Market Share by Application (2017-2022)

Table 50. Europe Plasma-derived Medicinal Products Sales by Country (2017-2022) & (K Units)

Table 51. Europe Plasma-derived Medicinal Products Sales Market Share by Country (2017-2022)

Table 52. Europe Plasma-derived Medicinal Products Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Plasma-derived Medicinal Products Revenue Market Share by Country (2017-2022)

Table 54. Europe Plasma-derived Medicinal Products Sales by Type (2017-2022) & (K Units)

Table 55. Europe Plasma-derived Medicinal Products Sales Market Share by Type (2017-2022)

Table 56. Europe Plasma-derived Medicinal Products Sales by Application (2017-2022) & (K Units)

Table 57. Europe Plasma-derived Medicinal Products Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Plasma-derived Medicinal Products Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Plasma-derived Medicinal Products Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Plasma-derived Medicinal Products Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Plasma-derived Medicinal Products Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Plasma-derived Medicinal Products Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Plasma-derived Medicinal Products Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Plasma-derived Medicinal Products Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Plasma-derived Medicinal Products Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Plasma-derived Medicinal Products

Table 67. Key Market Challenges & Risks of Plasma-derived Medicinal Products

Table 68. Key Industry Trends of Plasma-derived Medicinal Products

Table 69. Plasma-derived Medicinal Products Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Plasma-derived Medicinal Products Distributors List

Table 72. Plasma-derived Medicinal Products Customer List

Table 73. Global Plasma-derived Medicinal Products Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Plasma-derived Medicinal Products Sales Market Forecast by Region

Table 75. Global Plasma-derived Medicinal Products Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Plasma-derived Medicinal Products Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Plasma-derived Medicinal Products Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Plasma-derived Medicinal Products Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Plasma-derived Medicinal Products Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Plasma-derived Medicinal Products Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Plasma-derived Medicinal Products Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Plasma-derived Medicinal Products Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Plasma-derived Medicinal Products Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Plasma-derived Medicinal Products Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Plasma-derived Medicinal Products Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Plasma-derived Medicinal Products Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Plasma-derived Medicinal Products Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Plasma-derived Medicinal Products Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Plasma-derived Medicinal Products Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Plasma-derived Medicinal Products Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Plasma-derived Medicinal Products Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Plasma-derived Medicinal Products Revenue Market Share Forecast by Application (2023-2028)

Table 93. Novartis(CSL Limited) Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors

Table 94. Novartis(CSL Limited) Plasma-derived Medicinal Products Product Offered

Table 95. Novartis(CSL Limited) Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Novartis(CSL Limited) Main Business

Table 97. Novartis(CSL Limited) Latest Developments

Table 98. Biotest AG (Creat Group Corporation) Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors

Table 99. Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Product Offered

Table 100. Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. Biotest AG (Creat Group Corporation) Main Business

Table 102. Biotest AG (Creat Group Corporation) Latest Developments

Table 103. Grifols SA Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors

Table 104. Grifols SA Plasma-derived Medicinal Products Product Offered

Table 105. Grifols SA Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Grifols SA Main Business

Table 107. Grifols SA Latest Developments

Table 108. Sigma-Aldrich Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors

Table 109. Sigma-Aldrich Plasma-derived Medicinal Products Product Offered

Table 110. Sigma-Aldrich Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Sigma-Aldrich Main Business

Table 112. Sigma-Aldrich Latest Developments

Table 113. Thermo Fisher Scientific Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors

Table 114. Thermo Fisher Scientific Plasma-derived Medicinal Products Product Offered

Table 115. Thermo Fisher Scientific Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. Thermo Fisher Scientific Main Business

Table 117. Thermo Fisher Scientific Latest Developments

Table 118. Octapharma AG Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors

Table 119. Octapharma AG Plasma-derived Medicinal Products Product Offered

Table 120. Octapharma AG Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. Octapharma AG Main Business

Table 122. Octapharma AG Latest Developments

Table 123. Takeda Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors

Table 124. Takeda Plasma-derived Medicinal Products Product Offered

Table 125. Takeda Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Takeda Main Business

Table 127. Takeda Latest Developments

Table 128. Kedrion Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors

Table 129. Kedrion Plasma-derived Medicinal Products Product Offered

Table 130. Kedrion Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. Kedrion Main Business

Table 132. Kedrion Latest Developments

Table 133. China Biologic Products Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors

Table 134. China Biologic Products Plasma-derived Medicinal Products Product Offered

Table 135. China Biologic Products Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. China Biologic Products Main Business

Table 137. China Biologic Products Latest Developments

Table 138. LFB Group Basic Information, Plasma-derived Medicinal Products Manufacturing Base, Sales Area and Its Competitors

Table 139. LFB Group Plasma-derived Medicinal Products Product Offered

Table 140. LFB Group Plasma-derived Medicinal Products Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. LFB Group Main Business

Table 142. LFB Group Latest Developments

List of Figures

Figure 1. Picture of Plasma-derived Medicinal Products

Figure 2. Plasma-derived Medicinal Products Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Plasma-derived Medicinal Products Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Plasma-derived Medicinal Products Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Plasma-derived Medicinal Products Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Immunoglobulins

Figure 10. Product Picture of Coagulation Factor Concentrates

Figure 11. Product Picture of Other

Figure 12. Global Plasma-derived Medicinal Products Sales Market Share by Type in 2021

Figure 13. Global Plasma-derived Medicinal Products Revenue Market Share by Type (2017-2022)

Figure 14. Plasma-derived Medicinal Products Consumed in Emergency Care

Figure 15. Global Plasma-derived Medicinal Products Market: Emergency Care (2017-2022) & (K Units)

Figure 16. Plasma-derived Medicinal Products Consumed in Epidemic Diseasae

Figure 17. Global Plasma-derived Medicinal Products Market: Epidemic Diseasae (2017-2022) & (K Units)

Figure 18. Plasma-derived Medicinal Products Consumed in Immune System Disorder

Figure 19. Global Plasma-derived Medicinal Products Market: Immune System Disorder (2017-2022) & (K Units)

Figure 20. Plasma-derived Medicinal Products Consumed in Antibody Deficiency

Figure 21. Global Plasma-derived Medicinal Products Market: Antibody Deficiency (2017-2022) & (K Units)

Figure 22. Plasma-derived Medicinal Products Consumed in Coagulation Disorder

Figure 23. Global Plasma-derived Medicinal Products Market: Coagulation Disorder (2017-2022) & (K Units)

Figure 24. Plasma-derived Medicinal Products Consumed in Others

Figure 25. Global Plasma-derived Medicinal Products Market: Others (2017-2022) & (K Units)

Figure 26. Global Plasma-derived Medicinal Products Sales Market Share by Application (2017-2022)

Figure 27. Global Plasma-derived Medicinal Products Revenue Market Share by Application in 2021

Figure 28. Plasma-derived Medicinal Products Revenue Market by Company in 2021 ($ Million)

Figure 29. Global Plasma-derived Medicinal Products Revenue Market Share by Company in 2021

Figure 30. Global Plasma-derived Medicinal Products Sales Market Share by Geographic Region (2017-2022)

Figure 31. Global Plasma-derived Medicinal Products Revenue Market Share by Geographic Region in 2021

Figure 32. Global Plasma-derived Medicinal Products Sales Market Share by Region (2017-2022)

Figure 33. Global Plasma-derived Medicinal Products Revenue Market Share by Country/Region in 2021

Figure 34. Americas Plasma-derived Medicinal Products Sales 2017-2022 (K Units)

Figure 35. Americas Plasma-derived Medicinal Products Revenue 2017-2022 ($ Millions)

Figure 36. APAC Plasma-derived Medicinal Products Sales 2017-2022 (K Units)

Figure 37. APAC Plasma-derived Medicinal Products Revenue 2017-2022 ($ Millions)

Figure 38. Europe Plasma-derived Medicinal Products Sales 2017-2022 (K Units)

Figure 39. Europe Plasma-derived Medicinal Products Revenue 2017-2022 ($ Millions)

Figure 40. Middle East & Africa Plasma-derived Medicinal Products Sales 2017-2022 (K Units)

Figure 41. Middle East & Africa Plasma-derived Medicinal Products Revenue 2017-2022 ($ Millions)

Figure 42. Americas Plasma-derived Medicinal Products Sales Market Share by Country in 2021

Figure 43. Americas Plasma-derived Medicinal Products Revenue Market Share by Country in 2021

Figure 44. United States Plasma-derived Medicinal Products Revenue Growth 2017-2022 ($ Millions)

Figure 45. Canada Plasma-derived Medicinal Products Revenue Growth 2017-2022 ($ Millions)

Figure 46. Mexico Plasma-derived Medicinal Products Revenue Growth 2017-2022 ($ Millions)

Figure 47. Brazil Plasma-derived Medicinal Products Revenue Growth 2017-2022 ($ Millions)

Figure 48. APAC Plasma-derived Medicinal Products Sales Market Share by Region in 2021

Figure 49. APAC Plasma-derived Medicinal Products Revenue Market Share by Regions in 2021

Figure 50. China Plasma-derived Medicinal Products Revenue Growth 2017-2022 ($ Millions)

Figure 51. Japan Plasma-derived Medicinal Products Revenue Growth 2017-2022 ($ Millions)

Figure 52. South Korea Plasma-derived Medicinal Products Revenue Growth 2017-2022 ($ Millions)

Figure 53. Southeast Asia Plasma-derived Medicinal Products Revenue Growth 2017-2022 ($ Millions)

Figure 54. India Plasma-derived Medicinal Products Revenue Growth 2017-2022 ($ Millions)

Figure 55. Australia Plasma-derived Medicinal Products Revenue Growth 2017-2022 ($ Millions)

Figure 56. Europe Plasma-derived Medicinal Products Sales Market Share by Country in 2021

Figure 57. Europe Plasma-derived Medicinal Products Revenue Market Share by Country in 2021

Figure 58. Germany Plasma-derived Medicinal Products Revenue Growth 2017-2022 ($ Millions)

Figure 59. France Plasma-derived Medicinal Products Revenue Growth 2017-2022 ($ Millions)

Figure 60. UK Plasma-derived Medicinal Products Revenue Growth 2017-2022 ($ Millions)

Figure 61. Italy Plasma-derived Medicinal Products Revenue Growth 2017-2022 ($ Millions)

Figure 62. Russia Plasma-derived Medicinal Products Revenue Growth 2017-2022 ($ Millions)

Figure 63. Middle East & Africa Plasma-derived Medicinal Products Sales Market Share by Country in 2021

Figure 64. Middle East & Africa Plasma-derived Medicinal Products Revenue Market Share by Country in 2021

Figure 65. Egypt Plasma-derived Medicinal Products Revenue Growth 2017-2022 ($ Millions)

Figure 66. South Africa Plasma-derived Medicinal Products Revenue Growth 2017-2022 ($ Millions)

Figure 67. Israel Plasma-derived Medicinal Products Revenue Growth 2017-2022 ($ Millions)

Figure 68. Turkey Plasma-derived Medicinal Products Revenue Growth 2017-2022 ($ Millions)

Figure 69. GCC Country Plasma-derived Medicinal Products Revenue Growth 2017-2022 ($ Millions)

Figure 70. Manufacturing Cost Structure Analysis of Plasma-derived Medicinal Products in 2021

Figure 71. Manufacturing Process Analysis of Plasma-derived Medicinal Products

Figure 72. Industry Chain Structure of Plasma-derived Medicinal Products

Figure 73. Channels of Distribution

Figure 74. Distributors Profiles